Protecting the Pipeline: Building Life Sciences Patent Portfolios for Long-Term Value

Protecting the Pipeline: Building Life Sciences Patent Portfolios for Long-Term Value

View Session Speakers

Life sciences patent portfolios must protect far more than a single invention in order to provide long-term enterprise value. Effective portfolio strategy requires anticipating how a drug, biologic, diagnostic, platform technology, or therapeutic program may evolve from early discovery through clinical development, regulatory approval, commercialization, and lifecycle management.

This panel will examine how life sciences companies build layered patent protection around their most important products and pipelines. The discussion will explore claim strategy, continuation practice, global filing decisions, platform and product protection, formulations, methods of treatment, manufacturing innovations, diagnostics, and follow-on developments. Panelists will also consider how patent prosecution should be coordinated with regulatory milestones, competitive intelligence, partnering and financing activity, and the company’s broader commercial objectives.

The focus will not simply be on obtaining patents, but on building portfolios that remain strategically relevant as the science, competitive landscape, and business opportunity evolve.